Impact of Anatomical Extent and Combined Surgical–Medical Therapy on Survival in Sinonasal and Rhino-Orbito-Cerebral Mucormycosis: A 14-Year Retrospective ENT Cohort
Journal of Clinical Medicine · 24.12.2025 · 15 (1) · 127
DOI: 10.3390/jcm15010127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.12.2025. Verfasst von Günay Kozan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery Clinic, Dicle University Faculty of Medicine, 21010 Diyarbakir, Turkey. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Mucormycosis is a rapidly progressive invasive fungal infection that commonly involves the sinonasal region and skull base in patients with systemic comorbidities, yet robust ENT data from middle-income settings are scarce.
Methods
We performed a single-center retrospective review of all patients with histopathologically confirmed mucormycosis treated in the Otorhinolaryngology Department of Dicle University between 2010 and 2023, covering a 14-year period. Eligible patients had paranasal sinus computed tomography at presentation and received surgical and/or systemic antifungal therapy. Demographic data, comorbidities, disease subtype, radiological extent, treatment modality and survival were extracted from records. Survival was estimated using Kaplan–Meier analysis, and group differences were tested with chi-square statistics (p ≤ 0.05).
Results
Fifty-two patients met the inclusion criteria (mean age 56.5 ± 15.2 years; 57.7% male); 73.1% had at least one systemic comorbidity, most frequently diabetes mellitus (65.4%) and hematological malignancy (19.2%). Disease was sinonasal in 42.3%, rhino-orbital in 28.8% and rhino-orbito-cerebral in 28.8%. Baseline CT showed intracranial extension in 26.9%. Overall survival was 59.6% and differed markedly by subtype, highest in isolated sinonasal disease (81.8%) and lowest in rhino-orbito-cerebral disease (26.7%). Intracranial extension was associated with higher mortality (71.4% vs. 28.9%). Combined surgical debridement plus systemic antifungal therapy, used in 84.6% of patients, yielded lower mortality than antifungal therapy alone (31.8% vs. 87.5%).
Conclusions
In this ENT cohort, prognosis was mainly determined by anatomical extent and treatment strategy. Our findings suggest that timely combined surgical and antifungal management, when feasible and in appropriately selected patients, is associated with improved survival outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Head and Neck Surgery Clinic, Dicle University Faculty of Medicine, 21010 Diyarbakir, Turkey.
- Department of Otorhinolaryngology, University of Health Sciences Gazi Yasargil Training and Research Hospital, 21100 Diyarbakır, Turkey.
ORCID-Profile: Günay Kozan, Serkan Dedeoğlu, Muhammed Ayral
Zitieren
APA
Kozan, G., Dedeoğlu, S., Ayral, M., & Akdağ, M. (2025). Impact of Anatomical Extent and Combined Surgical–Medical Therapy on Survival in Sinonasal and Rhino-Orbito-Cerebral Mucormycosis: A 14-Year Retrospective ENT Cohort. Journal of Clinical Medicine, 15(1), 127. https://doi.org/10.3390/jcm15010127
Vancouver
Kozan G, Dedeoğlu S, Ayral M, Akdağ M. Impact of Anatomical Extent and Combined Surgical–Medical Therapy on Survival in Sinonasal and Rhino-Orbito-Cerebral Mucormycosis: A 14-Year Retrospective ENT Cohort. Journal of Clinical Medicine. 2025;15(1):127. doi:10.3390/jcm15010127
BibTeX
@article{Kozan2025,
author = {Kozan, Günay and Dedeoğlu, Serkan and Ayral, Muhammed and Akdağ, Mehmet},
title = {Impact of Anatomical Extent and Combined Surgical–Medical Therapy on Survival in Sinonasal and Rhino-Orbito-Cerebral Mucormycosis: A 14-Year Retrospective ENT Cohort},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {15},
number = {1},
pages = {127},
doi = {10.3390/jcm15010127}
}
EUVIMED